Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Business & Profession Business and Innovation, Health Economics and Policy, Retina, Comprehensive

Business in Brief

Alicia Tozier
  • Alicia Tozier joined Outlook Therapeutics as its Senior Vice President, Marketing and Marketing Access, to support the company’s goal of developing and launching the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications.
  • The first intraocular pseudophakic contact lens (IOPCL), AccuraSee, aimed to improve near vision in patients with AMD, was implanted by surgeons from Harvard Eye Associates in Laguna Hills, California, USA. The lens implant is designed to magnify images and allow patients to use parts of their retina not affected by the disease. 
  • HOYA Lens UK partnered with Haag-Streit UK to provide diagnostics and treatment for myopia, addressing the global rise of the condition in children. 
  • Aerie Pharmaceuticals, which develops and commercializes ophthalmic therapies for conditions such as DED, glaucoma, DME, and wet AMD, has appointed Peter F. Lang as the company’s CFO.
  • EyeBio, a company working on a portfolio of new-generation therapies for a plethora of ocular disorders, has successfully completed a funding round. The money will be used to assemble and develop a diversified pipeline of product candidates using innovative translational approaches.
Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Aleksandra Jones

Editor of The Ophthalmologist

Having edited several technical publications over the last decade, I crossed paths with quite a few of Texere's current team members, and I only ever heard them sing the company's praises. When an opportunity arose to join Texere, I jumped at the chance! With a background in literature, I love the company's ethos of producing genuinely engaging content, and the fact that it is so well received by our readers makes it even more rewarding.

Related Product Profile
Uncover the Unique DNA of SPECTRALIS®

| Contributed by Heidelberg Engineering

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register